| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4HNB3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005488 | binding | 1 | 7 |
| GO:0043167 | ion binding | 2 | 7 |
| GO:0043169 | cation binding | 3 | 7 |
| GO:0046872 | metal ion binding | 4 | 7 |
| GO:0003676 | nucleic acid binding | 3 | 1 |
| GO:0003723 | RNA binding | 4 | 1 |
| GO:0097159 | organic cyclic compound binding | 2 | 1 |
| GO:1901363 | heterocyclic compound binding | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.558 |
| CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.558 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.559 |
| DEG_SCF_FBW7_1 | 236 | 242 | PF00400 | 0.756 |
| DEG_SCF_FBW7_1 | 243 | 249 | PF00400 | 0.629 |
| DOC_CDC14_PxL_1 | 237 | 245 | PF14671 | 0.515 |
| DOC_CKS1_1 | 210 | 215 | PF01111 | 0.636 |
| DOC_CKS1_1 | 236 | 241 | PF01111 | 0.739 |
| DOC_CKS1_1 | 243 | 248 | PF01111 | 0.609 |
| DOC_CKS1_1 | 5 | 10 | PF01111 | 0.713 |
| DOC_PP4_FxxP_1 | 201 | 204 | PF00568 | 0.472 |
| DOC_PP4_FxxP_1 | 251 | 254 | PF00568 | 0.732 |
| DOC_USP7_MATH_1 | 109 | 113 | PF00917 | 0.506 |
| DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.615 |
| DOC_USP7_MATH_1 | 239 | 243 | PF00917 | 0.627 |
| DOC_USP7_MATH_1 | 255 | 259 | PF00917 | 0.675 |
| DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.680 |
| DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.606 |
| DOC_WW_Pin1_4 | 123 | 128 | PF00397 | 0.608 |
| DOC_WW_Pin1_4 | 140 | 145 | PF00397 | 0.677 |
| DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.535 |
| DOC_WW_Pin1_4 | 205 | 210 | PF00397 | 0.721 |
| DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.399 |
| DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.698 |
| DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.595 |
| DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.763 |
| LIG_AP2alpha_2 | 172 | 174 | PF02296 | 0.506 |
| LIG_BRCT_BRCA1_1 | 125 | 129 | PF00533 | 0.628 |
| LIG_FHA_1 | 13 | 19 | PF00498 | 0.679 |
| LIG_FHA_1 | 151 | 157 | PF00498 | 0.732 |
| LIG_FHA_1 | 210 | 216 | PF00498 | 0.612 |
| LIG_FHA_1 | 243 | 249 | PF00498 | 0.644 |
| LIG_FHA_1 | 95 | 101 | PF00498 | 0.734 |
| LIG_FHA_2 | 255 | 261 | PF00498 | 0.725 |
| LIG_FHA_2 | 87 | 93 | PF00498 | 0.509 |
| LIG_Integrin_isoDGR_2 | 191 | 193 | PF01839 | 0.529 |
| LIG_LIR_Apic_2 | 152 | 158 | PF02991 | 0.526 |
| LIG_LIR_Apic_2 | 249 | 254 | PF02991 | 0.726 |
| LIG_LIR_Nem_3 | 238 | 243 | PF02991 | 0.667 |
| LIG_LYPXL_yS_3 | 240 | 243 | PF13949 | 0.517 |
| LIG_SH2_GRB2like | 189 | 192 | PF00017 | 0.516 |
| LIG_SH2_PTP2 | 155 | 158 | PF00017 | 0.526 |
| LIG_SH2_PTP2 | 217 | 220 | PF00017 | 0.495 |
| LIG_SH2_SRC | 189 | 192 | PF00017 | 0.482 |
| LIG_SH2_STAP1 | 76 | 80 | PF00017 | 0.522 |
| LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.526 |
| LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.472 |
| LIG_SH2_STAT5 | 19 | 22 | PF00017 | 0.583 |
| LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.557 |
| LIG_SH3_3 | 2 | 8 | PF00018 | 0.768 |
| LIG_SH3_3 | 233 | 239 | PF00018 | 0.685 |
| LIG_SH3_3 | 63 | 69 | PF00018 | 0.669 |
| MOD_CK1_1 | 121 | 127 | PF00069 | 0.694 |
| MOD_CK1_1 | 128 | 134 | PF00069 | 0.665 |
| MOD_CK1_1 | 224 | 230 | PF00069 | 0.550 |
| MOD_CK1_1 | 235 | 241 | PF00069 | 0.671 |
| MOD_CK1_1 | 242 | 248 | PF00069 | 0.707 |
| MOD_CK1_1 | 258 | 264 | PF00069 | 0.562 |
| MOD_CK1_1 | 94 | 100 | PF00069 | 0.562 |
| MOD_CK2_1 | 178 | 184 | PF00069 | 0.564 |
| MOD_CK2_1 | 254 | 260 | PF00069 | 0.726 |
| MOD_CK2_1 | 86 | 92 | PF00069 | 0.514 |
| MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.663 |
| MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.664 |
| MOD_GSK3_1 | 103 | 110 | PF00069 | 0.575 |
| MOD_GSK3_1 | 121 | 128 | PF00069 | 0.685 |
| MOD_GSK3_1 | 162 | 169 | PF00069 | 0.635 |
| MOD_GSK3_1 | 174 | 181 | PF00069 | 0.496 |
| MOD_GSK3_1 | 205 | 212 | PF00069 | 0.608 |
| MOD_GSK3_1 | 235 | 242 | PF00069 | 0.674 |
| MOD_GSK3_1 | 254 | 261 | PF00069 | 0.604 |
| MOD_N-GLC_1 | 227 | 232 | PF02516 | 0.524 |
| MOD_NEK2_1 | 118 | 123 | PF00069 | 0.627 |
| MOD_NEK2_1 | 166 | 171 | PF00069 | 0.655 |
| MOD_NEK2_2 | 86 | 91 | PF00069 | 0.515 |
| MOD_PIKK_1 | 109 | 115 | PF00454 | 0.511 |
| MOD_PIKK_1 | 134 | 140 | PF00454 | 0.776 |
| MOD_PIKK_1 | 164 | 170 | PF00454 | 0.681 |
| MOD_PIKK_1 | 20 | 26 | PF00454 | 0.725 |
| MOD_Plk_1 | 131 | 137 | PF00069 | 0.545 |
| MOD_Plk_1 | 227 | 233 | PF00069 | 0.524 |
| MOD_Plk_4 | 113 | 119 | PF00069 | 0.560 |
| MOD_Plk_4 | 221 | 227 | PF00069 | 0.521 |
| MOD_Plk_4 | 48 | 54 | PF00069 | 0.643 |
| MOD_Plk_4 | 67 | 73 | PF00069 | 0.553 |
| MOD_Plk_4 | 96 | 102 | PF00069 | 0.652 |
| MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.605 |
| MOD_ProDKin_1 | 123 | 129 | PF00069 | 0.611 |
| MOD_ProDKin_1 | 140 | 146 | PF00069 | 0.678 |
| MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.530 |
| MOD_ProDKin_1 | 205 | 211 | PF00069 | 0.723 |
| MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.398 |
| MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.697 |
| MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.595 |
| MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.761 |
| TRG_DiLeu_BaLyEn_6 | 175 | 180 | PF01217 | 0.495 |
| TRG_ENDOCYTIC_2 | 240 | 243 | PF00928 | 0.700 |
| TRG_NLS_MonoExtN_4 | 196 | 201 | PF00514 | 0.542 |
| TRG_Pf-PMV_PEXEL_1 | 200 | 205 | PF00026 | 0.532 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I468 | Leptomonas seymouri | 33% | 100% |
| A0A3S7X9W1 | Leishmania donovani | 64% | 100% |
| A4IBY5 | Leishmania infantum | 64% | 100% |
| E9AFS2 | Leishmania major | 63% | 100% |
| E9B6X4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% |